RxDoctor Payments Data

Tracy Pride, PA

Physician Assistant · Lansing, MINPI 1548375934

Payments from drug & device makers

$7,096in general payments, 2019–2025

Across 254 payments — averaging $27.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$4K
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$530
  • Pfizer$414
  • Impulse Dynamics (USA) Inc.$306
  • Johnson & Johnson$248
  • E.r. Squibb & Sons, L.L.C.$247
  • plus $2K from 20 others

What the payments were for

  • Travel & lodging$2,33833%
  • Food & beverage$4,71366%
  • Education$451%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,096 in reported general payments places this provider in the 95th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Medicare billing

Part B allowed, 2024
$12,661
Medicare patients
142
Services billed
169

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban758$940,597
XareltoRivaroxaban164$222,956
MultaqDronedarone Hcl46$68,375
Dofetilide190$29,067
CorlanorIvabradine Hcl16$14,697
Amiodarone Hcl215$8,227
SotalolSotalol Hcl234$6,024
Flecainide Acetate120$5,942
Metoprolol Succinate265$4,979
Propafenone Hcl ErPropafenone Hcl20$4,358
Diltiazem 24hr Er (Cd)Diltiazem Hcl96$3,744
Dabigatran EtexilateDabigatran Etexilate Mesylate12$3,167
Midodrine Hcl21$1,488
Dilt-XrDiltiazem Hcl25$1,217
Metoprolol Tartrate105$1,030

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$414$940,597758 claims
Johnson & JohnsonXarelto$248$222,956164 claims
Sanofi-aventis U.S. LLCMultaq$22$68,37546 claims
AmgenCorlanor$229$14,69716 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in Lansing

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →